Patient-engaged Development and Testing of Educational Content on Side Effects of Statins

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

ENROLLING_BY_INVITATION

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2025-07-31

Study Completion Date

2026-07-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The purpose of this study is to learn about people's experiences and perspectives on side effects of statins and to use this information to develop and test educational content to help people understand statin side effects when they are newly prescribed a statin. Participants in the first phase of the study will fill out a survey and participate in a focus group or interview. Participants in the second phase of the study will view educational content, fill out a survey, and participate in two interviews.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Using Feedback Reports to Improve Medication Adherence

NCT02480530

Coronary Artery Disease Adherence

COMPLETED NA

Evaluating the Efficacy of Pediatric Lipid Screening Alerts

NCT04118348

Hypercholesterolemia Hypercholesterolemia, Familial Hypercholesteremia in Children +1 more

COMPLETED NA

Drug Facts Page or a Short Drug Summary in Helping Patients and Doctors Understand Medical Information

NCT00450931

Health Status Unknown

UNKNOWN NA

Social Forces to Improve Statin Adherence (Study A)

NCT02018809

Medication Adherence High Blood Pressure Diabetes

COMPLETED NA

Social Forces to Improve Statin Adherence (Study B)

NCT02148523

Medication Adherence High Blood Pressure Diabetes

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Dyslipidemia

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

NA

Intervention Model

SINGLE_GROUP

Primary Study Purpose

HEALTH_SERVICES_RESEARCH

Blinding Strategy

NONE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Educational intervention arm

Participants view educational content

Group Type EXPERIMENTAL

Educational content on statin side effects

Intervention Type OTHER

Participants will view educational content that will include written material, graphics and video. The content will explain side effects and benefits of statin medications. The content will also explain placebo and nocebo effects and how they may impact people taking statins.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Educational content on statin side effects

Participants will view educational content that will include written material, graphics and video. The content will explain side effects and benefits of statin medications. The content will also explain placebo and nocebo effects and how they may impact people taking statins.

Intervention Type OTHER

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Has at least one cardiovascular risk factor, including diabetes (DM), hypertension (HTN), hyperlipidemia (HLD), or a 10-year risk of atherosclerotic cardiovascular disease (ASCVD) of equal to or greater than 7.5%
* Able to speak and read English

Exclusion Criteria

* Established diagnosis of atherosclerotic cardiovascular disease (ASCVD), including coronary artery disease (CAD), peripheral arterial disease (PAD), or history of stroke
* Unable to access and engage with web-based education content for any reason (either independently or with the help of a support person)
* Is a healthcare professional at the college level or above, defined as a registered nurse, nurse practitioner, physician assistant, physician, dentist, or pharmacist
* Has a graduate-level degree of any kind
* Hospice or end-of-life

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No